Semin Respir Crit Care Med 2010; 31(6): 706-715
DOI: 10.1055/s-0030-1269830
© Thieme Medical Publishers

The Approach to the Patient with a Parapneumonic Effusion

John M. Wrightson1 , 2 , Robert J. O Davies1 , 2
  • 1Oxford Pleural Unit, Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom
  • 2NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
Further Information

Publication History

Publication Date:
06 January 2011 (online)

ABSTRACT

Parapneumonic effusions are seen in up to 57% of patients with pneumonia. The majority of these effusions are noninfected and resolve with standard antibiotic treatment for the associated pneumonia. However, parapneumonic effusions in a minority of cases become infected and require prompt chest tube drainage and occasionally thoracic surgery. Patients may present in a variety of ways from florid sepsis to weight loss and anorexia; such diversity mandates a high index of suspicion among physicians. The role of the combination of intrapleural deoxyribonuclease (DNase) and tissue plasminogen activator (t-PA) to aid fluid drainage shows promise but needs further assessment in large trials with surgery and mortality as primary end points.

REFERENCES

  • 1 Light R W, Girard W M, Jenkinson S G, George R B. Parapneumonic effusions.  Am J Med. 1980;  69 507-512
  • 2 Taryle D A, Potts D E, Sahn S A. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia.  Chest. 1978;  74 170-173
  • 3 Chalmers J D, Singanayagam A, Murray M P, Scally C, Fawzi A, Hill A T. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.  Thorax. 2009;  64 592-597
  • 4 Farjah F, Symons R G, Krishnadasan B, Wood D E, Flum D R. Management of pleural space infections: a population-based analysis.  J Thorac Cardiovasc Surg. 2007;  133 346-351
  • 5 Finley C, Clifton J, Fitzgerald J M, Yee J. Empyema: an increasing concern in Canada.  Can Respir J. 2008;  15 85-89
  • 6 Maskell N A, Batt S, Hedley E L, Davies C W, Gillespie S H, Davies R J. The bacteriology of pleural infection by genetic and standard methods and its mortality.  Am J Respir Crit Care Med. 2006;  174 817-823
  • 7 Alemán C, Alegre J, Monasterio J et al.. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.  Clin Sci (Lond). 2003;  105 601-607
  • 8 Kroegel C, Antony V B. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy.  Eur Respir J. 1997;  10 2411-2418
  • 9 Idell S, Girard W, Koenig K B, McLarty J, Fair D S. Abnormalities of pathways of fibrin turnover in the human pleural space.  Am Rev Respir Dis. 1991;  144 187-194
  • 10 Potts D E, Taryle D A, Sahn S A. The glucose-pH relationship in parapneumonic effusions.  Arch Intern Med. 1978;  138 1378-1380
  • 11 Sahn S A, Reller L B, Taryle D A, Antony V B, Good Jr J T. The contribution of leukocytes and bacteria to the low pH of empyema fluid.  Am Rev Respir Dis. 1983;  128 811-815
  • 12 Ferguson A D, Prescott R J, Selkon J B, Watson D, Swinburn C R. The clinical course and management of thoracic empyema.  Q J Med. 1996;  89 285-289
  • 13 Davies H E, Davies R J, Davies C W. BTS Pleural Disease Guideline Group . Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010.  Thorax. 2010;  65(Suppl 2) ii41-ii53
  • 14 Vignon P, Chastagner C, Berkane V et al.. Quantitative assessment of pleural effusion in critically ill patients by means of ultrasonography.  Crit Care Med. 2005;  33 1757-1763
  • 15 Tayal V S, Nicks B A, Norton H J. Emergency ultrasound evaluation of symptomatic nontraumatic pleural effusions.  Am J Emerg Med. 2006;  24 782-786
  • 16 Kocijancic I, Vidmar K, Ivanovi-Herceg Z. Chest sonography versus lateral decubitus radiography in the diagnosis of small pleural effusions.  J Clin Ultrasound. 2003;  31 69-74
  • 17 Feller-Kopman D. Therapeutic thoracentesis: the role of ultrasound and pleural manometry.  Curr Opin Pulm Med. 2007;  13 312-318
  • 18 Balik M, Plasil P, Waldauf P et al.. Ultrasound estimation of volume of pleural fluid in mechanically ventilated patients.  Intensive Care Med. 2006;  32 318-321
  • 19 Rahman N M, Singanayagam A, Davies H E et al.. Diagnostic accuracy, safety and utilisation of respiratory physician-delivered thoracic ultrasound.  Thorax. 2010;  65 449-453
  • 20 Eibenberger K L, Dock W I, Ammann M E, Dorffner R, Hörmann M F, Grabenwöger F. Quantification of pleural effusions: sonography versus radiography.  Radiology. 1994;  191 681-684
  • 21 Stavas J, vanSonnenberg E, Casola G, Wittich G R. Percutaneous drainage of infected and noninfected thoracic fluid collections.  J Thorac Imaging. 1987;  2 80-87
  • 22 Wrightson J M, Fysh E, Maskell N A, Lee Y C. Risk reduction in pleural procedures: sonography, simulation and supervision.  Curr Opin Pulm Med. 2010;  16 340-350
  • 23 Chen K Y, Liaw Y S, Wang H C, Luh K T, Yang P C. Sonographic septation: a useful prognostic indicator of acute thoracic empyema.  J Ultrasound Med. 2000;  19 837-843
  • 24 Himelman R B, Callen P W. The prognostic value of loculations in parapneumonic pleural effusions.  Chest. 1986;  90 852-856
  • 25 Tu C Y, Hsu W H, Hsia T C et al.. Pleural effusions in febrile medical ICU patients: chest ultrasound study.  Chest. 2004;  126 1274-1280
  • 26 Yang P C, Luh K T, Chang D B, Wu H D, Yu C J, Kuo S H. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases.  AJR Am J Roentgenol. 1992;  159 29-33
  • 27 Akhan O, Ozkan O, Akinci D, Hassan A, Ozmen M. Image-guided catheter drainage of infected pleural effusions.  Diagn Interv Radiol. 2007;  13 204-209
  • 28 Shankar S, Gulati M, Kang M, Gupta S, Suri S. Image-guided percutaneous drainage of thoracic empyema: can sonography predict the outcome?.  Eur Radiol. 2000;  10 495-499
  • 29 Müller N L. Imaging of the pleura.  Radiology. 1993;  186 297-309
  • 30 Stark D D, Federle M P, Goodman P C, Podrasky A E, Webb W R. Differentiating lung abscess and empyema: radiography and computed tomography.  AJR Am J Roentgenol. 1983;  141 163-167
  • 31 Aquino S L, Webb W R, Gushiken B J. Pleural exudates and transudates: diagnosis with contrast-enhanced CT.  Radiology. 1994;  192 803-808
  • 32 Waite R J, Carbonneau R J, Balikian J P, Umali C B, Pezzella A T, Nash G. Parietal pleural changes in empyema: appearances at CT.  Radiology. 1990;  175 145-150
  • 33 Takasugi J E, Godwin J D, Teefey S A. The extrapleural fat in empyema: CT appearance.  Br J Radiol. 1991;  64 580-583
  • 34 Skouras V, Awdankiewicz A, Light R W. What size parapneumonic effusions should be sampled?.  Thorax. 2010;  65 91
  • 35 Diacon A H, Brutsche M H, Solèr M. Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound.  Chest. 2003;  123 436-441
  • 36 Jones P W, Moyers J P, Rogers J T, Rodriguez R M, Lee Y C, Light R W. Ultrasound-guided thoracentesis: is it a safer method?.  Chest. 2003;  123 418-423
  • 37 Risks of chest drain insertion. Report from National Patient Safety Agency, UK 2008 Available at: http://www.npsa.nhs.uk/nrls/alerts-and-directives/rapidrr/risks-of-chest-drain-insertion/
  • 38 Maskell N A, Davies C W, Nunn A J First Multicenter Intrapleural Sepsis Trial (MIST1) Group et al. U.K. controlled trial of intrapleural streptokinase for pleural infection.  N Engl J Med. 2005;  352 865-874
  • 39 Porcel J M. Pearls and myths in pleural fluid analysis.  Respirology. 2010;  June 21. [Epub ahead of print]
  • 40 Saglani S, Harris K A, Wallis C, Hartley J C. Empyema: the use of broad range 16S rDNA PCR for pathogen detection.  Arch Dis Child. 2005;  90 70-73
  • 41 Heffner J E, Brown L K, Barbieri C, DeLeo J M. Pleural fluid chemical analysis in parapneumonic effusions: a meta-analysis.  Am J Respir Crit Care Med. 1995;  151 1700-1708
  • 42 Rahman N M, Mishra E K, Davies H E, Davies R J, Lee Y C. Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose.  Am J Respir Crit Care Med. 2008;  178 483-490
  • 43 Cheng D S, Rodriguez R M, Rogers J, Wagster M, Starnes D L, Light R W. Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip.  Chest. 1998;  114 1368-1372
  • 44 Lesho E P, Roth B J. Is pH paper an acceptable, low-cost alternative to the blood gas analyzer for determining pleural fluid pH?.  Chest. 1997;  112 1291-1292
  • 45 Pine J R, Hollman J L. Elevated pleural fluid pH in Proteus mirabilis empyema.  Chest. 1983;  84 109-111
  • 46 Davies C W, Kearney S E, Gleeson F V, Davies R J. Predictors of outcome and long-term survival in patients with pleural infection.  Am J Respir Crit Care Med. 1999;  160(5 Pt 1) 1682-1687
  • 47 Maskell N A, Gleeson F V, Darby M, Davies R J. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.  Chest. 2004;  126 2022-2024
  • 48 Huang H C, Chang H Y, Chen C W, Lee C H, Hsiue T R. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema.  Chest. 1999;  115 751-756
  • 49 Porcel J M. Pleural fluid tests to identify complicated parapneumonic effusions.  Curr Opin Pulm Med. 2010;  16 357-361
  • 50 Lin M C, Chen Y C, Wu J T, Ko Y C, Wang C C. Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions.  Chest. 2009;  136 205-211
  • 51 Porcel J M, Vives M, Cao G et al.. Biomarkers of infection for the differential diagnosis of pleural effusions.  Eur Respir J. 2009;  34 1383-1389
  • 52 Alfageme I, Muñoz F, Peña N, Umbría S. Empyema of the thorax in adults. Etiology, microbiologic findings, and management.  Chest. 1993;  103 839-843
  • 53 Ali I, Unruh H. Management of empyema thoracis.  Ann Thorac Surg. 1990;  50 355-359
  • 54 Galea J L, De Souza A, Beggs D, Spyt T. The surgical management of empyema thoracis.  J R Coll Surg Edinb. 1997;  42 15-18
  • 55 Landreneau R J, Keenan R J, Hazelrigg S R, Mack M J, Naunheim K S. Thoracoscopy for empyema and hemothorax.  Chest. 1996;  109 18-24
  • 56 LeMense G P, Strange C, Sahn S A. Empyema thoracis: therapeutic management and outcome.  Chest. 1995;  107 1532-1537
  • 57 Lemmer J H, Botham M J, Orringer M B. Modern management of adult thoracic empyema.  J Thorac Cardiovasc Surg. 1985;  90 849-855
  • 58 Mandal A K, Thadepalli H. Treatment of spontaneous bacterial empyema thoracis.  J Thorac Cardiovasc Surg. 1987;  94 414-418
  • 59 Sherman M M, Subramanian V, Berger R L. Management of thoracic empyema.  Am J Surg. 1977;  133 474-479
  • 60 Storm H K, Krasnik M, Bang K, Frimodt-Møller N. Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage.  Thorax. 1992;  47 821-824
  • 61 Bartlett J G. Anaerobic bacterial infections of the lung and pleural space.  Clin Infect Dis. 1993;  16(Suppl 4) S248-S255
  • 62 Bartlett J G, Gorbach S L, Thadepalli H, Finegold S M. Bacteriology of empyema.  Lancet. 1974;  1 338-340
  • 63 Brook I, Frazier E H. Aerobic and anaerobic microbiology of empyema: a retrospective review in two military hospitals.  Chest. 1993;  103 1502-1507
  • 64 Civen R, Jousimies-Somer H, Marina M et al.. A retrospective review of cases of anaerobic empyema and update of bacteriology.  Clin Infect Dis. 1995;  20(Suppl 2) S224-S229
  • 65 Lin Y C, Chen H J, Liu Y H, Shih C M, Hsu W H, Tu C Y. A 30-month experience of thoracic empyema in a tertiary hospital: emphasis on differing bacteriology and outcome between the medical intensive care unit (MICU) and medical ward.  South Med J. 2008;  101 484-489
  • 66 Tu C Y, Hsu W H, Hsia T C et al.. The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit.  Intensive Care Med. 2006;  32 570-576
  • 67 Ko S C, Chen K Y, Hsueh P R, Luh K T, Yang P C. Fungal empyema thoracis: an emerging clinical entity.  Chest. 2000;  117 1672-1678
  • 68 Dhiensiri T, Puapairoj S, Susaengrat W. Pulmonary melioidosis: clinical-radiologic correlation in 183 cases in northeastern Thailand.  Radiology. 1988;  166 711-715
  • 69 Hammond J M, Potgieter P D, Hanslo D, Scott H, Roditi D. The etiology and antimicrobial susceptibility patterns of microorganisms in acute community-acquired lung abscess.  Chest. 1995;  108 937-941
  • 70 Neild J E, Eykyn S J, Phillips I. Lung abscess and empyema.  Q J Med. 1985;  57 875-882
  • 71 Hughes C E, Van Scoy R E. Antibiotic therapy of pleural empyema.  Semin Respir Infect. 1991;  6 94-102
  • 72 Nathwani D, Wood M J. Penicillins: a current review of their clinical pharmacology and therapeutic use.  Drugs. 1993;  45 866-894
  • 73 Scaglione F, Raichi M, Fraschini F. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate.  J Antimicrob Chemother. 1990;  26(Suppl A) 1-10
  • 74 Taryle D A, Good Jr J T, Morgan III E J, Reller L B, Sahn S A. Antibiotic concentrations in human parapneumonic effusions.  J Antimicrob Chemother. 1981;  7 171-177
  • 75 Teixeira L R, Villarino M A. Antibiotic treatment of patients with pneumonia and pleural effusion.  Curr Opin Pulm Med. 1998;  4 230-234
  • 76 Shohet I, Yellin A, Meyerovitch J, Rubinstein E. Pharmacokinetics and therapeutic efficacy of gentamicin in an experimental pleural empyema rabbit model.  Antimicrob Agents Chemother. 1987;  31 982-985
  • 77 Teixeira L R, Sasse S A, Villarino M A, Nguyen T, Mulligan M E, Light R W. Antibiotic levels in empyemic pleural fluid.  Chest. 2000;  117 1734-1739
  • 78 Thys J P, Serruys-Schoutens E, Rocmans P, Herchuelz A, Vanderlinden M P, Yourassowsky E. Amikacin concentrations in uninfected postthoracotomy pleural fluid and in serum after intravenous and intrapleural injection.  Chest. 1984;  85 502-505
  • 79 Thys J P, Vanderhoeft P, Herchuelz A, Bergmann P, Yourassowsky E. Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas.  Chest. 1988;  93 530-532
  • 80 Meyer J A. Gotthard Bülau and closed water-seal drainage for empyema, 1875–1891.  Ann Thorac Surg. 1989;  48 597-599
  • 81 Peters R M. Empyema thoracis: historical perspective.  Ann Thorac Surg. 1989;  48 306-308
  • 82 Ashbaugh D G. Empyema thoracis: factors influencing morbidity and mortality.  Chest. 1991;  99 1162-1165
  • 83 Cham C W, Haq S M, Rahamim J. Empyema thoracis: a problem with late referral?.  Thorax. 1993;  48 925-927
  • 84 Heffner J E, McDonald J, Barbieri C, Klein J. Management of parapneumonic effusions: an analysis of physician practice patterns.  Arch Surg. 1995;  130 433-438
  • 85 Sasse S, Nguyen T K, Mulligan M, Wang N S, Mahutte C K, Light R W. The effects of early chest tube placement on empyema resolution.  Chest. 1997;  111 1679-1683
  • 86 Rahman N M, Maskell N A, Davies C W et al.. The relationship between chest tube size and clinical outcome in pleural infection.  Chest. 2010;  137 536-543
  • 87 Merriam M A, Cronan J J, Dorfman G S, Lambiase R E, Haas R A. Radiographically guided percutaneous catheter drainage of pleural fluid collections.  AJR Am J Roentgenol. 1988;  151 1113-1116
  • 88 Silverman S G, Mueller P R, Saini S et al.. Thoracic empyema: management with image-guided catheter drainage.  Radiology. 1988;  169 5-9
  • 89 Ulmer J L, Choplin R H, Reed J C. Image-guided catheter drainage of the infected pleural space.  J Thorac Imaging. 1991;  6 65-73
  • 90 Westcott J L. Percutaneous catheter drainage of pleural effusion and empyema.  AJR Am J Roentgenol. 1985;  144 1189-1193
  • 91 Havelock T, Teoh R, Laws D, Gleeson F. BTS Pleural Disease Guideline Group . Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010.  Thorax. 2010;  65(Suppl 2) ii61-ii76
  • 92 Wrightson J M, Helm E J, Rahman N M, Gleeson F V, Davies R J. Pleural procedures and pleuroscopy.  Respirology. 2009;  14 796-807
  • 93 Shoseyov D, Bibi H, Shatzberg G et al.. Short-term course and outcome of treatments of pleural empyema in pediatric patients: repeated ultrasound-guided needle thoracocentesis vs chest tube drainage.  Chest. 2002;  121 836-840
  • 94 Simmers T A, Jie C, Sie B. Minimally invasive treatment of thoracic empyema.  Thorac Cardiovasc Surg. 1999;  47 77-81
  • 95 Tillett W S, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations.  J Clin Invest. 1949;  28 173-190
  • 96 Aye R W, Froese D P, Hill L D. Use of purified streptokinase in empyema and hemothorax.  Am J Surg. 1991;  161 560-562
  • 97 Bergh N P, Ekroth R, Larsson S, Nagy P. Intrapleural streptokinase in the treatment of haemothorax and empyema.  Scand J Thorac Cardiovasc Surg. 1977;  11 265-268
  • 98 Berglin E, Ekroth R, Teger-Nilsson A C, William-Olsson G. Intrapleural instillation of streptokinase: effects on systemic fibrinolysis.  Thorac Cardiovasc Surg. 1981;  29 124-126
  • 99 Bouros D, Schiza S, Panagou P, Drositis J, Siafakas N. Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema.  Thorax. 1994;  49 852-855
  • 100 Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas N M. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study.  Am J Respir Crit Care Med. 1997;  155 291-295
  • 101 Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study.  Am J Respir Crit Care Med. 1999;  159 37-42
  • 102 Cameron R, Davies H R. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.  Cochrane Database Syst Rev. 2008;  (2) CD002312
  • 103 Chin N K, Lim T K. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions.  Chest. 1997;  111 275-279
  • 104 Cohen M L, Finch I J. Transcatheter intrapleural urokinase for loculated pleural effusion.  Chest. 1994;  105 1874-1876
  • 105 Davies C W, Lok S, Davies R J. The systemic fibrinolytic activity of intrapleural streptokinase.  Am J Respir Crit Care Med. 1998;  157 328-330
  • 106 Davies R J, Traill Z C, Gleeson F V. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection.  Thorax. 1997;  52 416-421
  • 107 Diacon A H, Theron J, Schuurmans M M, Van de Wal B W, Bolliger C T. Intrapleural streptokinase for empyema and complicated parapneumonic effusions.  Am J Respir Crit Care Med. 2004;  170 49-53
  • 108 Fraedrich G, Hofmann D, Effenhauser P, Jander R. Instillation of fibrinolytic enzymes in the treatment of pleural empyema.  Thorac Cardiovasc Surg. 1982;  30 36-38
  • 109 Godley P J, Bell R C. Major hemorrhage following administration of intrapleural streptokinase.  Chest. 1984;  86 486-487
  • 110 Henke C A, Leatherman J W. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions.  Am Rev Respir Dis. 1992;  145 680-684
  • 111 Jerjes-Sánchez C, Ramirez-Rivera A, Elizalde J J et al.. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial.  Chest. 1996;  109 1514-1519
  • 112 Laisaar T, Püttsepp E, Laisaar V. Early administration of intrapleural streptokinase in the treatment of multiloculated pleural effusions and pleural empyemas.  Thorac Cardiovasc Surg. 1996;  44 252-256
  • 113 Misthos P, Sepsas E, Konstantinou M et al.. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema: a prospective study.  Eur J Cardiothorac Surg. 2005;  28 599-603
  • 114 Mitchell M E, Alberts W M, Chandler K W, Goldman A L. Intrapleural streptokinase in management of parapneumonic effusions: report of series and review of literature.  J Fla Med Assoc. 1989;  76 1019-1022
  • 115 Moulton J S, Benkert R E, Weisiger K H, Chambers J A. Treatment of complicated pleural fluid collections with image-guided drainage and intracavitary urokinase.  Chest. 1995;  108 1252-1259
  • 116 Moulton J S, Moore P T, Mencini R A. Treatment of loculated pleural effusions with transcatheter intracavitary urokinase.  AJR Am J Roentgenol. 1989;  153 941-945
  • 117 Ogirala R G, Williams Jr M H. Streptokinase in a loculated pleural effusion: effectiveness determined by site of instillation.  Chest. 1988;  94 884-886
  • 118 Park C S, Chung W M, Lim M K, Cho C H, Suh C H, Chung W K. Transcatheter instillation of urokinase into loculated pleural effusion: analysis of treatment effect.  AJR Am J Roentgenol. 1996;  167 649-652
  • 119 Pollak J S, Passik C S. Intrapleural urokinase in the treatment of loculated pleural effusions.  Chest. 1994;  105 868-873
  • 120 Porter J, Banning A P. Intrapleural streptokinase.  Thorax. 1998;  53 720
  • 121 Robinson L A, Moulton A L, Fleming W H, Alonso A, Galbraith T A. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas.  Ann Thorac Surg. 1994;  57 803-813 discussion 813-804
  • 122 Roupie E, Bouabdallah K, Delclaux C et al.. Intrapleural administration of streptokinase in complicated purulent pleural effusion: a CT-guided strategy.  Intensive Care Med. 1996;  22 1351-1353
  • 123 Ryan J M, Boland G W, Lee M J, Mueller P R. Intracavitary urokinase therapy as an adjunct to percutaneous drainage in a patient with a multiloculated empyema.  AJR Am J Roentgenol. 1996;  167 643-647
  • 124 Talib S H, Verma G R, Arshad M, Tayade B O, Rafeeque A. Utility of intrapleural streptokinase in management of chronic empyemas.  J Assoc Physicians India. 2003;  51 464-468
  • 125 Taylor R F, Rubens M B, Pearson M C, Barnes N C. Intrapleural streptokinase in the management of empyema.  Thorax. 1994;  49 856-859
  • 126 Temes R T, Follis F, Kessler R M, Pett Jr S B, Wernly J A. Intrapleural fibrinolytics in management of empyema thoracis.  Chest. 1996;  110 102-106
  • 127 Thomson A H, Hull J, Kumar M R, Wallis C, Balfour Lynn I M. Randomised trial of intrapleural urokinase in the treatment of childhood empyema.  Thorax. 2002;  57 343-347
  • 128 Tuncozgur B, Ustunsoy H, Sivrikoz M C et al.. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial.  Int J Clin Pract. 2001;  55 658-660
  • 129 Willsie-Ediger S K, Salzman G, Reisz G, Foreman M G. Use of intrapleural streptokinase in the treatment of thoracic empyema.  Am J Med Sci. 1990;  300 296-300
  • 130 Light R W, Nguyen T, Mulligan M E, Sasse S A. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema.  Lung. 2000;  178 13-18
  • 131 Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus.  Chest. 2000;  117 1728-1733
  • 132 Rahman N M, Maskell N, Davies CWH et al.. Primary result of the second Multicentre Intrapleural Sepsis (MIST2) Trial; randomised trial of intrapleural tPA and DNase in pleural infection.  Thorax. 2009;  64 A1
  • 133 Martella A T, Santos G H. Decortication for chronic postpneumonic empyema.  J Am Coll Surg. 1995;  180 573-576
  • 134 Tacconi F, Pompeo E, Fabbi E, Mineo T C. Awake video-assisted pleural decortication for empyema thoracis.  Eur J Cardiothorac Surg. 2010;  37 594-601
  • 135 Wait M A, Sharma S, Hohn J, Dal Nogare A. A randomized trial of empyema therapy.  Chest. 1997;  111 1548-1551
  • 136 Sonnappa S, Cohen G, Owens C M et al.. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema.  Am J Respir Crit Care Med. 2006;  174 221-227
  • 137 Bilgin M, Akcali Y, Oguzkaya F. Benefits of early aggressive management of empyema thoracis.  ANZ J Surg. 2006;  76 120-122
  • 138 Melloni G, Carretta A, Ciriaco P et al.. Decortication for chronic parapneumonic empyema: results of a prospective study.  World J Surg. 2004;  28 488-493
  • 139 Jimenez Castro D, Diaz G, Perez-Rodriguez E, Light R W. Prognostic features of residual pleural thickening in parapneumonic pleural effusions.  Eur Respir J. 2003;  21 952-955
  • 140 Martínez M A, Cordero P J, Cases E et al.. Prognostic features of residual pleural thickening in metapneumonic pleural effusion.  [in Spanish] Arch Bronconeumol. 1999;  35 108-112
  • 141 Colice G L, Curtis A, Deslauriers J et al.. Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.  Chest. 2000;  118 1158-1171

John M WrightsonM.A. 

Oxford Pleural Unit, Oxford Centre for Respiratory Medicine

Churchill Hospital, Oxford OX3 7LJ, UK

Email: johnwrightson@thorax.org.uk

    >